We are a bioincubator helping emerging biotechs decreasing their time to seed funding.

We have a growing commitment to engineering innovation that improves health industry efficiency.

latest news older news

Univercells raises €16M is series B round led by GHIF

Univercells empowers its international technology transfer to China, India and Latin America by bringing together an ambitious series B syndicate of investors. Led by GHIF, a social impact investment fund structured by JPMorgan Chase & Co and The Bill & Melinda Gates Foundation, the syndicate includes Belgian technology investors: The Innovation Fund and Inventures II. Read the official press release here.

Read more

inOvO is looking for a Business Developer

inOvO, an in-creation UMONS spin-off, developing innovative endocrine disruptors detection tests is looking for a Business Developer. Interested ? Discover the full mission description here

Read more
Learn more about our events all events next event

MedTech Booster

Market opportunity validation

This one day booster aims at advising early stage MedTech projects on how to conduct a professional market validation...

Read more